REFERENCES
- Borm P. J. A., Robbins D., Haubold S., Kuhlbusch T., Fissan H., Donaldson K., Schins R., Stone V., Kreyling W., Lademann J., Krutmann J., Warheit D., Oberdörster E. The potential risks of nanomaterials: A review carried out for ECETOC. Particle Fibre Toxicol. 2006; 3: 11
- ECETOC. Testing strategies to establish the safety of nanomaterials. European Centre for Ecotoxicology and Toxicology of Chemicals, BrusselsBelgium August, 2006, 7–8 November 2005, Barcelona. Workshop Report No. 7
- Oberdörster G., Maynard A., Donaldson K., Castranova V., Fitzpatrick J., Ausman K., Carter J., Karn B., Kreyling W., Lai D., Olin S., Monteiro-Riviere N., Warheit D., Yang H. A report from the ILSI Research Foundation/Risk Science Institute. Nanomaterial Toxicity Screening Working Group. Principles for characterizing the potential human health effects from exposure to nanomaterials: Elements of a screening strategy. Particle Fibre Toxicol. 2005; 2: 8
- Radomski A., Jurasz P., Alonso-Escolano D., Drews A. M., Morandi M., Malinski T., Radomski M. W. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br. J. Pharmacol. 2005; 146: 882–893